Invasive pulmonary aspergillosis in patients with influenza infection: Report of two cases and systematic review of the literature

Khaled Alshabani, Athar Haq, Ryo Miyakawa, Mohan Palla, Ayman O. Soubani

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Superinfection or coinfections are major causes of morbidity and mortality in patients with influenza. There are limited data on invasive pulmonary aspergillosis (IPA) in this setting. We conducted a systematic review of the literature for patients with IPA following influenza infection. A total of 68 patients (two reported from our institution and 66 identified by literature review) were analyzed. The majority of patients had underlying comorbid illnesses. Overall, the mortality rate in this cohort was 47%. On multivariate analysis, H1N1 infection was associated with better outcome (odds ratio [OR]: 0.19; 95% CI: 0.05-0.67; p = 0.010), whereas corticosteroid therapy during hospitalization was associated with worse outcome (OR: 13.5; 95% CI: 3.65-49.67; p < 0.0001). In conclusion, IPA is an emerging serious infection in patients with influenza. A high index of suspicion is necessary for the timely identification and treatment of these patients.

Original languageEnglish (US)
Pages (from-to)89-96
Number of pages8
JournalExpert Review of Respiratory Medicine
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Invasive Pulmonary Aspergillosis
Human Influenza
Infection
Odds Ratio
Superinfection
Mortality
Coinfection
Adrenal Cortex Hormones
Hospitalization
Multivariate Analysis
Morbidity
Therapeutics

Keywords

  • Aspergillosis
  • H1N1 influenza
  • infections
  • influenza
  • Outcome

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health

Cite this

Invasive pulmonary aspergillosis in patients with influenza infection : Report of two cases and systematic review of the literature. / Alshabani, Khaled; Haq, Athar; Miyakawa, Ryo; Palla, Mohan; Soubani, Ayman O.

In: Expert Review of Respiratory Medicine, Vol. 9, No. 1, 01.01.2015, p. 89-96.

Research output: Contribution to journalReview article

@article{e69533f69f684dc385ffc8796197fb45,
title = "Invasive pulmonary aspergillosis in patients with influenza infection: Report of two cases and systematic review of the literature",
abstract = "Superinfection or coinfections are major causes of morbidity and mortality in patients with influenza. There are limited data on invasive pulmonary aspergillosis (IPA) in this setting. We conducted a systematic review of the literature for patients with IPA following influenza infection. A total of 68 patients (two reported from our institution and 66 identified by literature review) were analyzed. The majority of patients had underlying comorbid illnesses. Overall, the mortality rate in this cohort was 47{\%}. On multivariate analysis, H1N1 infection was associated with better outcome (odds ratio [OR]: 0.19; 95{\%} CI: 0.05-0.67; p = 0.010), whereas corticosteroid therapy during hospitalization was associated with worse outcome (OR: 13.5; 95{\%} CI: 3.65-49.67; p < 0.0001). In conclusion, IPA is an emerging serious infection in patients with influenza. A high index of suspicion is necessary for the timely identification and treatment of these patients.",
keywords = "Aspergillosis, H1N1 influenza, infections, influenza, Outcome",
author = "Khaled Alshabani and Athar Haq and Ryo Miyakawa and Mohan Palla and Soubani, {Ayman O.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1586/17476348.2015.996132",
language = "English (US)",
volume = "9",
pages = "89--96",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Invasive pulmonary aspergillosis in patients with influenza infection

T2 - Report of two cases and systematic review of the literature

AU - Alshabani, Khaled

AU - Haq, Athar

AU - Miyakawa, Ryo

AU - Palla, Mohan

AU - Soubani, Ayman O.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Superinfection or coinfections are major causes of morbidity and mortality in patients with influenza. There are limited data on invasive pulmonary aspergillosis (IPA) in this setting. We conducted a systematic review of the literature for patients with IPA following influenza infection. A total of 68 patients (two reported from our institution and 66 identified by literature review) were analyzed. The majority of patients had underlying comorbid illnesses. Overall, the mortality rate in this cohort was 47%. On multivariate analysis, H1N1 infection was associated with better outcome (odds ratio [OR]: 0.19; 95% CI: 0.05-0.67; p = 0.010), whereas corticosteroid therapy during hospitalization was associated with worse outcome (OR: 13.5; 95% CI: 3.65-49.67; p < 0.0001). In conclusion, IPA is an emerging serious infection in patients with influenza. A high index of suspicion is necessary for the timely identification and treatment of these patients.

AB - Superinfection or coinfections are major causes of morbidity and mortality in patients with influenza. There are limited data on invasive pulmonary aspergillosis (IPA) in this setting. We conducted a systematic review of the literature for patients with IPA following influenza infection. A total of 68 patients (two reported from our institution and 66 identified by literature review) were analyzed. The majority of patients had underlying comorbid illnesses. Overall, the mortality rate in this cohort was 47%. On multivariate analysis, H1N1 infection was associated with better outcome (odds ratio [OR]: 0.19; 95% CI: 0.05-0.67; p = 0.010), whereas corticosteroid therapy during hospitalization was associated with worse outcome (OR: 13.5; 95% CI: 3.65-49.67; p < 0.0001). In conclusion, IPA is an emerging serious infection in patients with influenza. A high index of suspicion is necessary for the timely identification and treatment of these patients.

KW - Aspergillosis

KW - H1N1 influenza

KW - infections

KW - influenza

KW - Outcome

UR - http://www.scopus.com/inward/record.url?scp=84920996948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920996948&partnerID=8YFLogxK

U2 - 10.1586/17476348.2015.996132

DO - 10.1586/17476348.2015.996132

M3 - Review article

C2 - 25547335

AN - SCOPUS:84920996948

VL - 9

SP - 89

EP - 96

JO - Expert Review of Respiratory Medicine

JF - Expert Review of Respiratory Medicine

SN - 1747-6348

IS - 1

ER -